Literature DB >> 23850804

Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.

Oscar Krijgsman1, Patricia Gonzalez, Olga Balagué Ponz, Margaretha G M Roemer, Stefanie Slot, Annegien Broeks, Linde Braaf, Ron M Kerkhoven, Freek Bot, Krijn van Groningen, Max Beijert, Bauke Ylstra, Daphne de Jong.   

Abstract

Nodal marginal zone lymphoma is a poorly defined entity in the World Health Organization classification, based largely on criteria of exclusion and the diagnosis often remains subjective. Follicular lymphoma lacking t(14;18) has similar characteristics which results in a major potential diagnostic overlap which this study aims to dissect. Four subgroups of lymphoma samples (n=56) were analyzed with high-resolution array comparative genome hybridization: nodal marginal zone lymphoma, t(14;18)-negative follicular lymphoma, localized t(14:18)-positive follicular lymphoma and disseminated t(14;18)-positive follicular lymphoma. Gains on chromosomes 7, 8 and 12 were observed in all subgroups. The mean number of aberrations was higher in disseminated t(14;18)-positive follicular lymphoma than in localized t(14:18)-positive follicular lymphoma (P<0.01) and the majority of alterations in localized t(14:18)-positive follicular lymphoma were also found in disseminated t(14;18)-positive follicular lymphoma. Nodal marginal zone lymphoma was marked by 3q gains with amplifications of four genes. A different overall pattern of aberrations was seen in t(14;18)-negative follicular lymphoma compared to t(14;18)-positive follicular lymphoma. t(14;18)-negative follicular lymphoma is characterized by specific (focal) gains on chromosome 3, as observed in nodal marginal zone lymphoma. Our results support the notion that localized t(14:18)-positive follicular lymphoma represents an early phase of disseminated t(14;18)-positive follicular lymphoma. t(14;18)-negative follicular lymphoma bears aberrations that are more like those in nodal marginal zone lymphoma, suggesting a relation between these groups.

Entities:  

Mesh:

Year:  2013        PMID: 23850804      PMCID: PMC3856968          DOI: 10.3324/haematol.2013.085118

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  33 in total

Review 1.  Treatment strategies in follicular lymphomas: current status and future perspectives.

Authors:  Wolfgang Hiddemann; Christian Buske; Martin Dreyling; Oliver Weigert; Georg Lenz; Roswitha Forstpointner; Christina Nickenig; Michael Unterhalt
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

2.  Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Authors:  Annuska M Glas; Laurent Knoops; Leonie Delahaye; Marie José Kersten; Robby E Kibbelaar; Lodewyk A Wessels; Ryan van Laar; J Han J M van Krieken; Joke W Baars; John Raemaekers; Philip M Kluin; Laura J van't Veer; Daphne de Jong
Journal:  J Clin Oncol       Date:  2007-01-02       Impact factor: 44.544

Review 3.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

4.  Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.

Authors:  Margit Schraders; Daphne de Jong; Philip Kluin; Patricia Groenen; Han van Krieken
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

5.  Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.

Authors:  Douglas E Horsman; Ichiro Okamoto; Olga Ludkovski; Nhu Le; Lana Harder; Stefan Gesk; Reiner Siebert; Mukesh Chhanabhai; Laurie Sehn; Joseph M Connors; Randy D Gascoyne
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

6.  Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment.

Authors:  Annuska M Glas; Marie José Kersten; Leonie J M J Delahaye; Anke T Witteveen; Robby E Kibbelaar; Arno Velds; Lodewyk F A Wessels; Peter Joosten; Ron M Kerkhoven; René Bernards; Johan H J M van Krieken; Philip M Kluin; Laura J van't Veer; Daphne de Jong
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

7.  Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.

Authors:  Mariska Bierkens; Oscar Krijgsman; Saskia M Wilting; Leontien Bosch; Annelieke Jaspers; Gerrit A Meijer; Chris J L M Meijer; Peter J F Snijders; Bauke Ylstra; Renske D M Steenbergen
Journal:  Genes Chromosomes Cancer       Date:  2012-09-14       Impact factor: 5.006

Review 8.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

9.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

10.  A multiplex PCR predictor for aCGH success of FFPE samples.

Authors:  E H van Beers; S A Joosse; M J Ligtenberg; R Fles; F B L Hogervorst; S Verhoef; P M Nederlof
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

View more
  6 in total

1.  Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers.

Authors:  Michiel van den Brand; Janneke J M Mathijssen; Mar Garcia-Garcia; Konnie M Hebeda; Patricia J T A Groenen; Brunangelo Falini; Sergio Serrano; J Han J M van Krieken
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

3.  Early lesions of follicular lymphoma: a genetic perspective.

Authors:  Emilie Mamessier; Joo Y Song; Franziska C Eberle; Svetlana Pack; Charlotte Drevet; Bruno Chetaille; Ziedulla Abdullaev; José Adelaïde; Daniel Birnbaum; Max Chaffanet; Stefania Pittaluga; Sandrine Roulland; Andreas Chott; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

Review 4.  The broad landscape of follicular lymphoma: Part I.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Stefano Ascani
Journal:  Pathologica       Date:  2020-01-22

5.  Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.

Authors:  Imran N Siddiqi; Julia Friedman; Keegan Q Barry-Holson; Charles Ma; Venkata Thodima; Irene Kang; Raghavendra Padmanabhan; Lizalynn M Dias; Kevin R Kelly; Russell K Brynes; Sitharthan Kamalakaran; Jane Houldsworth
Journal:  Mod Pathol       Date:  2016-03-11       Impact factor: 8.209

6.  A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma.

Authors:  Michiel van den Brand; Olga Balagué; Patricia H J van Cleef; Patricia J T A Groenen; Konnie M Hebeda; Daphne de Jong; J Han J M van Krieken
Journal:  J Hematop       Date:  2015-09-02       Impact factor: 0.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.